Heroin (Opioid) Treatment
Author(s) -
Jamshid Ahmadi
Publication year - 2016
Publication title -
juniper online journal of case studies
Language(s) - English
Resource type - Journals
ISSN - 2476-1370
DOI - 10.19080/jojcs.2016.01.555562
Subject(s) - heroin , opioid , medicine , anesthesia , pharmacology , drug , receptor
Heroin is one of the derivative of morphine and also an opioid mu receptor agonist that was earlier presented as a non-addictive medication. Buprenorphine was accepted by the Food and Drug Administration (FDA) for the management of heroin withdrawal symptoms. Buprenorphine is considered as a partial mu agonist and also a secure drug with low chance of toxicity and overdose [1]. For the therapy of heroin dependence, buprenorphine is more useful than methadone [2-4]. Investigators such as Johnson, Jaffe, and Fudaladescribed that 8mg of sublingualbuprenorphine per day is equal to 60mg of methadone considering retention rates and opioids negative urines as well [5]. Buprenorphinecan diminish the incidence of HIV and other connected disorders following opioidsconsumption [1,6-8].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom